Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness and Safety of Princess FILLER Lidocaine in Correction of Nasolabial Folds (NLF)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* over or equal 22 years at screening~* approximately symmetrical moderate to severe nasolabial folds~* negative urine pregnancy test~* healthy skin~* willing to abstain from aesthetic or surgical procedures in the treatment area~* written informed consent~Exclusion Criteria:~* pregnant and/or lactating~* history of allergies or hypersensitivity to e.g. hyaluronic acid preparations~* tendency to keloid formation~* HIV positive~* presence of infectious, inflammatory or proliferative cancerous or pre-cancerous lesions~* herpes simplex in treatment area~* autoimmune or connective tissue disease, immunomodulating therapy~* uncontrolled diabetes or systemic diseases~* Facial plastic surgery, tissue augmentation~* implantation of facial dermal fillers within 12 months~* Skin of nasolabial region affected by aesthetic treatments~* Facial lipolysis~* Bariatric surgery within 12 months~* History of bleeding disorder~* Planned dental/oral surgery~* Any medical condition prohibiting the inclusion according to the investigator~* Previous enrollment~* Current participation in another clinical investigation within 30 days prior to enrollment~* Dependency of the subject to the investigation site

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Treatment of device 1 on left side (Type: OTHER): Treatment of nasolabial folds (NLF) with both Investigational Device and Comparator; Princess Filler Lidocaine is assigned to left NLF, Comparator is assigned to right NLF
- Treatment of device 1 on right side (Type: OTHER): Treatment of nasolabial folds (NLF) with both Investigational Device and Comparator; Princess Filler Lidocaine is assigned to right NLF, Comparator is assigned to left NLF

Based on this trial design, predict the completion outcome and termination type (if applicable).